Drug
Fasudil clinical trials
- studies test it
- 14
- open now
- 2
- in phase 3
- 2
- first study started
- 2002
Keep track of what changes. Save the fasudil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 12
- Phase 3
- 2
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 11
Woolsey Pharmaceuticals (3) · Brigham and Women's Hospital (2) · Technical University of Munich (1) · University Medical Center Goettingen (1) · Colorado State University (1) · Johns Hopkins University (1) · Helse Stavanger HF (1) · Zhejiang Provincial People's Hospital (1)
Studies
Open first, then newest update. How each study uses fasudil is read from its arms, and is right about nine times in ten.
Testing it · 14
- Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)RecruitingPhase 2Helse Stavanger HFNCT06362707Written as Fasudil
- A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian CancerRecruitingPhase 2Zhejiang Provincial People's HospitalNCT06890858Written as Fasudil Hydrochloride
- Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's DiseaseCompletedPhase 2Technical University of MunichNCT05931575Written as Fasudil hydrochloride
- Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)Active, not recruitingPhase 2Woolsey PharmaceuticalsNCT05218668Written as Fasudil (WP-0512)
- Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALSCompletedPhase 2University Medical Center GoettingenNCT03792490Written as Fasudil
- Fasudil fOr redUcing elopemeNt and Spatial DisorientationCompletedPhase 2Woolsey PharmaceuticalsNCT04793659Written as Oral Fasudil 90 mg/day
- Rho Kinase (ROCK) Inhibitor in Tauopathies - 1Status unknownPhase 2Woolsey PharmaceuticalsNCT04734379Written as Fasudil
- Red Blood Cell ATP Release and Vascular Function in HumansCompletedPhase 2Colorado State UniversityNCT03404843Written as Fasudil Hydrochloride
- Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)Status unknownPhase 2/3Shahid Beheshti University of Medical SciencesNCT04191954Written as Fasudil eye drops (concentration 0.5 percent)
- Early Intracoronary Administration of Fasudil in the Primary PCI of ST-segment-Elevation Myocardial InfarctionStatus unknownPhase 4RenJi HospitalNCT03753269Written as Fasudil Hydrochloride
- Rho Kinase (ROCK) Inhibition in Carotid AtherosclerosisTerminatedPhase 2Brigham and Women's HospitalNCT00670202Written as Fasudil Hydrochloride
- A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's PhenomenonCompletedPhase 3Johns Hopkins UniversityNCT00498615Written as Fasudil
- A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)Status unknownPhase 2Peking University Third HospitalNCT01935518Written as Fasudil
- The Effect of Fasudil on Vascular Function in HumansCompletedPhase 2Brigham and Women's HospitalNCT00120718Written as fasudil
Codes
What other systems call fasudil · ClinicalTrials.gg INT003281
- MeSH (NLM) C049347fasudilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Q0CH43PGXSFASUDILConfirmed FDA, NLM, Wikidata
- Wikidata Q5437132fasudilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65624FasudilOne source FDA
- DrugBank DB08162One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C049347 | fasudil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Q0CH43PGXS | FASUDIL | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5437132 | fasudil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65624 | Fasudil | One source FDA |
| DrugBank | DB08162 | — | One source Wikidata |
Also registered as fasudil hydrochloride (UNII SQ04N8S7BR).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.